Figure 1From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndromeEffect of telmisartan and losartan on measures of glycaemia and insulin resistance in 40 patients with metabolic syndrome. FPG = fasting plasma glucose, FPI = fasting plasma insulin, HOMA-IR = homeostatic model assessment – insulin resistance, HbA1c = glycosylated haemoglobin.Back to article page